Related Experiment Video
Updated: Aug 3, 2025

An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
Systematic comparison of approaches to analyze clustered competing risks data
Sabrina Schmitt1, Anika Buchholz2, Ann-Kathrin Ozga3
1Koblenz University of Applied Science, RheinAhrCampus Remagen, Joseph-Rovan-Allee 2, 53424, Remagen, Germany.
This study compares methods for analyzing competing events in clustered clinical trial data. The Katsahian et al. model demonstrated superior performance for unbiased effect estimation and prognosis.
Area of Science:
- Biostatistics
- Clinical Trials
- Epidemiology
Background:
- Clinical trials often analyze time-to-event data, facing challenges from competing events and multi-center cluster structures.
- Existing analyses frequently address either competing events or clustering, but not both simultaneously.
- There is a need for systematic comparison of methods handling both competing events and data clustering.
Purpose of the Study:
- To systematically compare four statistical approaches for analyzing competing events in the presence of data clustering.
- To evaluate method performance using both a real-world dataset and extensive simulations.
- To identify the most reliable method for applied researchers in complex clinical trial designs.
Main Methods:
- Comparison of four analytical methods: cause-specific Cox model with frailty, Fine and Gray model, and two extensions (Katsahian et al., Zhou et al.).
- Evaluation based on bias, square root of mean squared error (RMSE), and statistical power.
- Utilized a real-life clinical trial dataset and a comprehensive simulation study.
Main Results:
- The Katsahian et al. model exhibited the best performance across nearly all simulated scenarios.
- This model excelled in minimizing bias and RMSE while maximizing statistical power.
- It uniquely provided both unbiased effect estimation and accurate prognosis.
Conclusions:
- The systematic comparison guides researchers in selecting appropriate methods for competing events with clustered data.
- The Katsahian et al. approach is recommended due to its robust performance and dual capability for estimation and prognosis.
- This work enhances the analytical toolkit for complex clinical trial data analysis.
Related Concept Videos
Comparing the Survival Analysis of Two or More Groups
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Statistical Methods for Analyzing Epidemiological Data
Hazard Ratio
For example, in a clinical trial...
The Mantel-Cox Log-Rank Test
Relative Risk

